Somatostatin therapy in l-asparaginase-induced pancreatitis
โ Scribed by Cheung, Y. F. ;Lee, C. W. ;Chan, C. F. ;Chan, K. L. ;Lau, Y. L. ;Yeung, C. Y.
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 365 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
LโAsparaginaseโinduced pancreatitis is an uncommon but potentially lethal complication. An 8โyearโold girl with acute lymphoblastic leukaemia developed acute pancreatitis following treatment with asparaginase. Clinical and laboratory improvements were evident after treatment with somatostatin, with no complications of pancreatitis. Induction therapy for the leukaemia was able to be continued and complete remission was documented during the course of pancreatitis and somatostatin treatment, suggesting a beneficial role of somatostatin in the management of asparaginaseโinduced pancreatitis. ยฉ 1994 WileyโLiss, inc.
๐ SIMILAR VOLUMES
## Abstract LโAsparaginaseโinduced coagulation abnormalities were observed in all patients receiving this drug. All patients studied demonstrated low factor IX and fibrinogen levels and most (75%) had low levels of factor XI. Disturbances in other factors were much less frequent. Despite the presen
## Background. Octreotide is a synthetic somatostatin analogue which has been suggested for use in the management of acute pancreatitis. While studies have looked at octreotide use in the setting of pancreatitis due to chronic alcohol use or trauma, little is known of its role in management of dru